UBS Group Trims Owens & Minor (NYSE:OMI) Target Price to $26.00

Owens & Minor (NYSE:OMIFree Report) had its target price cut by UBS Group from $28.00 to $26.00 in a research report released on Monday morning, Benzinga reports. They currently have a buy rating on the stock.

OMI has been the topic of several other research reports. JPMorgan Chase & Co. lowered their price target on shares of Owens & Minor from $21.00 to $19.00 and set an underweight rating on the stock in a research report on Friday, November 17th. TheStreet downgraded shares of Owens & Minor from a c- rating to a d+ rating in a report on Thursday, October 12th. StockNews.com started coverage on Owens & Minor in a report on Thursday, October 5th. They issued a hold rating on the stock. Finally, Barclays started coverage on Owens & Minor in a research note on Wednesday, January 3rd. They set an equal weight rating and a $21.00 target price for the company. One research analyst has rated the stock with a sell rating, five have given a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat.com, Owens & Minor currently has a consensus rating of Hold and an average target price of $21.17.

Read Our Latest Stock Report on Owens & Minor

Owens & Minor Price Performance

Shares of OMI opened at $19.71 on Monday. The firm has a market capitalization of $1.51 billion, a PE ratio of -12.80, a price-to-earnings-growth ratio of 4.41 and a beta of 0.39. The company has a debt-to-equity ratio of 2.38, a current ratio of 1.23 and a quick ratio of 0.60. Owens & Minor has a 1-year low of $11.79 and a 1-year high of $23.66. The company’s fifty day moving average price is $20.14 and its 200-day moving average price is $18.15.

Owens & Minor (NYSE:OMIGet Free Report) last announced its quarterly earnings data on Friday, November 3rd. The company reported $0.44 earnings per share for the quarter, beating analysts’ consensus estimates of $0.38 by $0.06. Owens & Minor had a negative net margin of 1.14% and a positive return on equity of 8.06%. The firm had revenue of $2.59 billion for the quarter, compared to analyst estimates of $2.58 billion. During the same period in the previous year, the company earned $0.41 earnings per share. The business’s quarterly revenue was up 3.8% compared to the same quarter last year. On average, equities research analysts predict that Owens & Minor will post 1.35 EPS for the current year.

Insider Activity at Owens & Minor

In related news, SVP Jonathan A. Leon sold 7,500 shares of Owens & Minor stock in a transaction that occurred on Wednesday, January 17th. The shares were sold at an average price of $18.08, for a total value of $135,600.00. Following the completion of the sale, the senior vice president now owns 83,213 shares in the company, valued at approximately $1,504,491.04. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Owens & Minor news, CEO Perry A. Bernocchi sold 19,302 shares of the firm’s stock in a transaction that occurred on Wednesday, November 22nd. The shares were sold at an average price of $18.75, for a total value of $361,912.50. Following the completion of the transaction, the chief executive officer now owns 164,347 shares of the company’s stock, valued at approximately $3,081,506.25. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Jonathan A. Leon sold 7,500 shares of the firm’s stock in a transaction that occurred on Wednesday, January 17th. The shares were sold at an average price of $18.08, for a total transaction of $135,600.00. Following the completion of the transaction, the senior vice president now directly owns 83,213 shares of the company’s stock, valued at approximately $1,504,491.04. The disclosure for this sale can be found here. In the last quarter, insiders sold 54,970 shares of company stock worth $1,016,524. Insiders own 3.59% of the company’s stock.

Hedge Funds Weigh In On Owens & Minor

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. US Bancorp DE boosted its position in Owens & Minor by 67.4% in the 1st quarter. US Bancorp DE now owns 1,145 shares of the company’s stock valued at $51,000 after buying an additional 461 shares during the period. Lindbrook Capital LLC lifted its position in shares of Owens & Minor by 60.6% during the 2nd quarter. Lindbrook Capital LLC now owns 1,487 shares of the company’s stock worth $28,000 after purchasing an additional 561 shares during the last quarter. Nomura Asset Management Co. Ltd. lifted its position in shares of Owens & Minor by 68.3% during the 1st quarter. Nomura Asset Management Co. Ltd. now owns 1,700 shares of the company’s stock worth $25,000 after purchasing an additional 690 shares during the last quarter. DekaBank Deutsche Girozentrale purchased a new stake in shares of Owens & Minor during the 3rd quarter worth $29,000. Finally, Quadrant Capital Group LLC lifted its position in shares of Owens & Minor by 51.3% during the 2nd quarter. Quadrant Capital Group LLC now owns 2,437 shares of the company’s stock worth $46,000 after purchasing an additional 826 shares during the last quarter. Hedge funds and other institutional investors own 98.04% of the company’s stock.

About Owens & Minor

(Get Free Report)

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates in two segments, Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.

Featured Articles

Analyst Recommendations for Owens & Minor (NYSE:OMI)

Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with MarketBeat.com's FREE daily email newsletter.